TP Guide to Authors 2016-06-22

Total Page:16

File Type:pdf, Size:1020Kb

TP Guide to Authors 2016-06-22 View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by GSI Repository Guide for Authors About the Journal ...................................................................... 1 Post-Acceptance .........................................................................4 Article Type Specificatio ns ....................................................... 2 Costs.............................................................................................5 Preparation of Articles .............................................................. 2 Editorial Policies.........................................................................5 How to Submit ........................................................................... 4 Further Informatio n ...................................................................9 ABOUT THE JOURNAL Aims and Scope Journal Details Psychiatry has suffered tremendously by the limited Editor: translational pipeline. Nobel laureate Julius Axelrod’s Julio Licinio, MD discovery in 1957 of monoamine reuptake by pre-synaptic Deputy Director, Translational Medicine and Head, Mind neurons still forms the basis of contemporary antidepressant and Brain Theme treatment. There is a substantial gap between the explosion of South Australian Health and Medical Research Institute knowledge in neuroscience and conceptually novel treatments for our patients. Strategic Professor of Psychiatry Flinders University in Adelaide, South Australia Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical Editorial office: applications, healthcare and global health. We view Nature Publishing Group, 75 Varick St, 9th Floor, New York translation broadly, as the full spectrum of work that marks NY 10013 the pathway from discovery to global health. The steps of [email protected] translation that are within the scope of Translational Psychiatry include Impact factor: 5.538 (2015 Journal Citation Reports , Thomson (i) fundamental discovery, Reuters) (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) Abstracted in: translation to policy and health care guidelines, (v) PubMed/MEDLINE assessment of health policy and usage, and PubMed Central (vi) global health. Scopus ISI Web of Science All areas of medical research, including – but not restricted to DOAJ – molecular biology, genetics, pharmacology, imaging British Library and epidemiology are welcome as they contribute to Crossref enhance the field of translational psychiatry. Translational Psychiatry invites submissions of original articles and reviews, along with invited editorials and perspectives, all of which fall within the field of translational psychiatry. Rev ised January 20, 2015 1 ARTICLE TYPE SPECIFICATIONS Abstract Tables/ Article Description Word Limit References Figures Abstract: 250 words Unstructured Original Articles abstract Article: 5,000 words Max of 5 Max of 100 Please see ‘Preparation of Articles ’ below for details. excluding abstract and references. Abstract: 250 words Unstructured Max of 6-8 Max of 150 Reviews abstract Article: 6,000 words Correspondence Correspondence contributions must respond to an original research article published in Translational Psychiatry no earlier than six months prior to the proposed letter’s submission. Original authors will have the opportunity to respond to the No abstract Article: 700 words letter, should it be chosen for acceptance. This response will Max of 1 Max of 10 required (900 if no image) be published alongside the correspondence. Correspondence should contain no original or novel data. Contributions should start with a two- or three-sentence paragraph that contains the message of the article without specialized terminology. Joint first authors are not allowed. In consultation with the author, the editor may change the title of a Correspondence. PREPARATION OF ARTICLES Please note that original articles must contain the following also include a Conflict of Interest statement, which is also components. Please see below for further details. included in the text of the manuscript (see Editorial Policy • Cover letter (must include a Conflict of Interest section). statement) • Title page (excluding acknowledgements) Title Page: The title page should bear the title of the paper, • Abstract the full names of all the authors, highest academic degree • Introduction obtained, and their affiliations; also, the name, full postal • Materials (or patients) and Methods address, telephone and fax numbers and e-mail address of • Results the author to whom correspondence and offprint requests • Discussion are to be sent (This information is also asked for on the • Acknowledgements electronic submission site). The title should be brief, • Conflict of Interest informative, of 150 characters or less and should not make a statement or conclusion. The running title should consist of • References not more than 50 letters and spaces. It should be as brief as • Figure legends possible, convey the essential message of the paper and • Tables contain no abbreviations. • Figures Abstract: The Abstract should consist of one, single, Cover Letter: The uploaded cover letter must state the continuous paragraph 150-250 words in length. material is original research, has not been previously published and has not been submitted for publication elsewhere while under consideration. The cover letter must Rev ised January 20, 2015 2 Introduction: The Introduction should assume that the Journal article, up to six authors followed by et al.: reader is knowledgeable in the field and should therefore be Barbosa MDFS, Ngyen QA, Tchernev VT, Ashley JA, Detter as brief as possible but can include a short historical review JC, Blaydes SM et al. Identification of the homologous beige where desirable. and Chediak-Higashi syndrome genes. Nature 1996; 382 : 262-65. Materials/Subjects and Methods: This section should Journal article, e-pub ahead of print: contain sufficient detail, so that all experimental procedures Yolken RH, Torrey EF. Are some cases of psychosis caused can be reproduced, and include references. Methods, by microbial agents? A review of the evidence. Mol however, that have been published in detail elsewhere Psychiatry 2008; e-pub ahead of print 12 February 2008; should not be described in detail. Authors should provide doi:10.1038/mp.2008.5. the name of the manufacturer and their location for any specifically named medical equipment and instruments, and Journal article, in press: all drugs should be identified by their pharmaceutical names, Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider and by their trade name if relevant. L et al. ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Results and Discussion: The Results section should briefly Neuropsychopharmacology (in press). present the experimental data in text, tables or figures. Tables and figures should not be described extensively in the text, Complete book: either. The discussion should focus on the interpretation and Badcock C. Evolutionary Psychology: A Critical Introduction. the significance of the findings with concise objective Polity Press: Cambridge, UK, 2000. comments that describe their relation to other work in the area. It should not repeat information in the results. The Chapter in book: final paragraph should highlight the main conclusion(s), Panksepp J. Affective neuroscience: a conceptual framework and provide some indication of the direction future research for the neurobiological study of emotions. In Strongman K should take. (ed). International Reviews of Emotion Research. Wiley: Chichester, UK, 1991, pp 59–99. Acknowledgements: These should be brief, and should include sources of support including sponsorship (e.g. Abstract : university, charity, commercial organization) and sources of Pasanen J. Epigenetics and bipolar disorder. Am J Med Genet material (e.g. novel drugs) not available commercially. C Semin Med Genet 2003; 123 (Suppl 1): 45 (abstract 678). Conflict of Interest: Authors must declare whether or not Letter to the Editor there are any competing financial interests in relation to the Kyritsis AP, Rao JS. Cloning the differences between two work described. This information must be included at this complex genomes [letter]. Science 1993; 259: 946. stage and will be published as part of the paper. Conflict of interest should be noted in the cover letter and as part of the EndNote users should select The Pharmacogenomics submission process. Please see the Conflict of Interest Journal output style for the correct reference style. documentation in the Editorial Policy section for detailed information. Tables: These should be labeled sequentially and cited within the text. Each table should be presented on its own References: Only papers directly related to the article should page, numbered, and titled. Reference to table footnotes be cited. Exhaustive lists should be avoided. References should be made by means of Arabic numerals. Tables should follow the Vancouver format. In the text, they should should not duplicate the content of the text. They should appear as numbers, and at the end of the paper they should consist of at least two columns; columns should always have be listed (double-spaced) in numerical order corresponding headings. Authors should ensure that the data in the tables to the order of citation in the text. All authors should be are consistent with those cited
Recommended publications
  • Print Special Issue Flyer
    IMPACT FACTOR 5.923 an Open Access Journal by MDPI Molecular Psychiatry Guest Editors: Message from the Guest Editors Prof. Dr. Theo Rein Dear Colleagues, Department of Translational Science in Psychiatry, Max Planck Understanding the molecular underpinnings of the Institute of Psychiatry, 80804 pathophysiology of psychiatric disorders remains a Munich, Germany challenging task. Nevertheless, the field of molecular [email protected] psychiatry has greatly benefitted from the rapid Dr. Gabriel R. Fries technological advancements over the last few years. Translational Psychiatry Significant progress has been made in deciphering the Program, Louis A. Faillace, MD, genetic and epigenetic basis of psychiatric disorders at Department of Psychiatry and unprecedented resolution. A more comprehensive Behavioral Sciences, Center for Precision Health, School of molecular understanding of psychiatric diseases also is a Biomedical Informatics, Houston, prerequisite for the rational development of new drugs and TX, USA treatment strategies. [email protected] We encourage submissions addressing the role of molecular, genetic, epigenetic and biochemical mechanisms on all aspects related to pathophysiology, Deadline for manuscript vulnerability and resilience, response to treatment, submissions: prognosis, pharmacology and progression of psychiatric closed (31 March 2019) disorders. Dr. Theo Rein Dr. Gabriel R. Fries Guest Editors mdpi.com/si/14141 SpeciaIslsue IMPACT FACTOR 5.923 an Open Access Journal by MDPI Editor-in-Chief Message from
    [Show full text]
  • Nature Publishing Group Publishing Nature
    Catalog 2015 Nature Publishing Group Nature Nature Publishing Group Catalog 2015 Contents NPG publications by subject area 2-3 Nature Reviews Cancer 49 NPG in the community 4-7 Nature Reviews Cardiology 50 Open access at NPG 8-11 Nature Reviews Clinical Oncology 51 NPG linked data platform 13 Nature Reviews Disease Primers NEW in 2015 52 Using nature.com 14-18 Nature Reviews Drug Discovery 53 Blogs, podcasts and videos 20 Nature Reviews Endocrinology 54 Librarian gateway 22 Nature Reviews Gastroenterology & Hepatology 55 Site license information 23 Nature Reviews Genetics 56 Nature Reviews Immunology 57 Nature 24 Nature Reviews Microbiology 58 Nature archive 25 Nature Reviews Molecular Cell Biology 59 Scientific American 26 Nature Reviews Nephrology 60 Scientific American archive 27 Nature Reviews Neurology 61 Nature Reviews Neuroscience 62 Nature Biotechnology 29 Nature Reviews Rheumatology 63 Nature Cell Biology 30 Nature Reviews Urology 64 Nature Chemical Biology 31 Nature Chemistry 32 npj Aging and Mechanisms of Disease NEW in 2015 66 Nature Climate Change 33 npj Biofilms and Microbiomes 67 Nature Communications 34 npj Primary Care Respiratory Medicine 68 Nature Genetics 35 npj Schizophrenia 69 Nature Geoscience 36 AJG (The American Journal of Gastroenterology) 71 Nature Immunology 37 APS (Acta Pharmacologica Sinica) 72 Nature Materials 38 BDJ (British Dental Journal) 73 Nature Medicine 39 BDJ Team 74 Nature Methods 40 BJC (British Journal of Cancer) 75 Nature Nanotechnology 41 Blood Cancer Journal 76 Nature Neuroscience 42 BoneKEy
    [Show full text]
  • Nature Publishing Group Publishing Nature
    Nature Publishing Group Publishing Group Nature Nature Publishing Group Catalog 2013 日本語版 Scientifi c and medical excellence in print and online Catalog 2013 日本語版 目次 分 野 別 タイトルリスト 2-3 Nature Reviews Cancer 46 コミュニティーにおけるNP Gの 活 動 4-7 Nature Reviews Cardiology 47 NPGで のオープンアクセス 8-9 Nature Reviews Clinical Oncology 48 NPG Linked Data Platformについて 10 Nature Reviews Drug Discovery 49 nature.comの利用について 12-17 Nature Reviews Endocrinology 50 サイトライセンス情 報 18 Nature Reviews Gastroenterology & Hepatology 51 ライブラリアン・ゲートウェイ 19 Nature Reviews Genetics 52 Nature Reviews Immunology 53 Nature 20 Nature Reviews Microbiology 54 Nature archive 21 Nature Reviews Molecular Cell Biology 55 Nature ダ イジェスト 22 Nature Reviews Nephrology 56 Scientific American 24 Nature Reviews Neurology 57 Scientific American archive 25 Nature Reviews Neuroscience 58 Nature Reviews Rheumatology 59 Nature Biotechnology 27 Nature Reviews Urology 60 Nature Cell Biology 28 Nature Chemical Biology 29 The American Journal of Gastroenterology 62 Nature Chemistry 30 APS (Acta Pharmacologica Sinica) 63 Nature Climate Change 31 Asian Journal of Andrology 64 Nature Communications 32 BDJ (British Dental Journal) 65 Nature Genetics 33 BJC (British Journal of Cancer) 66 Nature Geoscience 34 Blood Cancer Journal 67 Nature Immunology 35 BoneKEy Reports 68 Nature Materials 36 Bone Marrow Transplantation 69 Nature Medicine 37 Cancer Gene Therapy 70 Nature Methods 38 Cell Death & Differentiation 71 Nature Nanotechnology 39 Cell Death & Disease 72 Nature Neuroscience 40 Cell Research 73 Nature Photonics
    [Show full text]
  • Print Special Issue Flyer
    IMPACT FACTOR 5.923 an Open Access Journal by MDPI Molecular Psychiatry 2.0 Guest Editors: Message from the Guest Editors Prof. Dr. Theo Rein Dear Colleagues, Department of Translational Science in Psychiatry, Max Planck Understanding the molecular underpinnings of the Institute of Psychiatry, 80804 pathophysiology of psychiatric disorders remains a Munich, Germany challenging task. Nevertheless, the field of molecular [email protected] psychiatry has greatly benefitted from the rapid Dr. Gabriel R. Fries technological advancements over the last few years. Translational Psychiatry Significant progress has been made in deciphering the Program, Louis A. Faillace, MD, genetic and epigenetic basis of psychiatric disorders at Department of Psychiatry and unprecedented resolution. A more comprehensive Behavioral Sciences, Center for Precision Health, School of molecular understanding of psychiatric diseases also is a Biomedical Informatics, Houston, prerequisite for the rational development of new drugs and TX, USA treatment strategies. [email protected] We encourage submissions addressing the role of molecular, genetic, epigenetic and biochemical mechanisms on all aspects related to pathophysiology, Deadline for manuscript vulnerability and resilience, response to treatment, submissions: prognosis, pharmacology and progression of psychiatric closed (31 August 2020) disorders. Dr. Theo Rein Dr. Gabriel R. Fries Guest Editors mdpi.com/si/36734 SpeciaIslsue IMPACT FACTOR 5.923 an Open Access Journal by MDPI Editor-in-Chief Message
    [Show full text]
  • Julio Licinio Research Professor University of Southern California USA Dr
    OMICS international OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosts over 700 leading-edge peer reviewed Open Access Journals and organizes over 1000 International Conferences annually all over the world. OMICS International journals have over 10 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50000 eminent personalities that ensure a rapid, quality and quick review process. OMICS International signed an agreement with more than 1000 International Societies to make healthcare information Open Access. Contact us at: [email protected] OMICS Journals are welcoming Submissions OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible way. OMICS Journals are poised in excellence by publishing high quality research. OMICS International follows an Editorial Manager® System peer review process and boasts of a strong and active editorial board. Editors and reviewers are experts in their field and provide anonymous, unbiased and detailed reviews of all submissions. The journal gives the options of multiple language translations for all the articles and all archived articles are available in HTML, XML, PDF and audio formats. Also, all the published articles are archived in repositories and indexing services like DOAJ, CAS, Google Scholar, Scientific Commons, Index Copernicus, EBSCO, HINARI and GALE. For more details please visit our website: http://omicsonline.org/Submitmanuscript.php Julio Licinio Research Professor University of Southern California USA Dr. Julio Licinio, M.D., F.A.P.A., is Professor and Director, John Curtin School of Medicine, The Australian National University, and head of the Department of Translational Medicine.
    [Show full text]
  • Special Issue on Moral Injury for Frontiers in Psychiatry Call For
    Special Issue on Moral Injury for Frontiers in Psychiatry Call for submissions to Frontiers in Psychiatry. A special issue of the journal is being devoted to “Screening for and Treatment of Moral Injury in Veterans/Active Duty Military with PTSD.” All are invited to submit to the journal a research study, commentary, or brief report/literature review on this topic. We are hoping that this special issue helps to mainstream the topic of moral injury into the field of psychiatry. For more information and to submit an article, go to https://www.frontiersin.org/research-topics/7377/screening- for-and-treatment-of-moral-injury-in-veteransactive-duty-military-with-ptsd. Frontiers in Psychiatry journal information (do not confuse with “Frontiers in Psychology”) Information Thomson-Reuter’s Impact Factor=3.53 (2016) Indexed in PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, PsycINFO, EMBASE, Science Citation Index Expanded, CLOCKSS, Social Science Citation Index Journal Ranking Frontiers in Psychiatry is ranked #52 among the top 100 Psychiatry and Mental Health journals, compared to JAMA Psychiatry (#1), American Journal of Psychiatry (#5), Lancet Psychiatry (#7), British Journal of Psychiatry (#14), Journal of Psychiatric Research (#37), Psychiatric Services (#59), Journal of Traumatic Stress (#61), Psychological Assessment (#74), Canadian Journal of Psychiatry (#82), and BMC Psychiatry (#96) (Source: http://www.scimagojr.com/journalrank.php?category=2738&page=1&total_size=497) Ranked 7th among the top 12 journals that are Open
    [Show full text]